Hironori Kaneko
Hironori Kaneko publishes mostly in Surgery, Oncology and Hepatology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research and Organ Transplantation Techniques and Outcomes.
- World rank
- #1,738,189 of 7,710,434 ranked researchers
- Rank in Japan
- #29,572 of 383,136
- Works
- 285
- Citations
- 8.9k
- Citations per work
- 31.2
What does Hironori Kaneko research?
Hironori Kaneko's work is mostly in Medicine (69%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19869.4%
- Medicine19869.4%
- Everything else8730.6%
- 1Surgery25% of their works
- 2Oncology13% of their works
- 3Hepatology13% of their works
- 4Pulmonary and Respiratory Medicine11% of their works
- 5Epidemiology4% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Pancreatic and Hepatic Oncology Research
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Surgical Treatments
- Gastric Cancer Management and Outcomes
- Gallbladder and Bile Duct Disorders
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Hironori Kaneko's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Hepatocellular Carcinoma, Liver Cancer, Neoadjuvant Therapy, Chemotherapy, Cholangiocarcinoma, Prognostic Factors and Surgical Management.
- Sunitinib
- ERCP
- Gastric Cancer
- Rectal Cancer
- Intrahepatic Cholangiocarcinoma
- Liver Transplantation
- Surgical Complications
- Surgical Management
- Cholangiocarcinoma
- Neoadjuvant Therapy
- Hepatocellular Carcinoma
- Clinical Practice Guidelines
- Liver Cancer
- Chemotherapy
- Prognostic Factors
- Pancreatic Cancer
- Ischemia-Reperfusion Injury
- Biliary Tract Cancer
- Preoperative Chemoradiotherapy
- Endoscopic Resection
- Cholecystitis
- Imatinib Mesylate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Practice Guidelines1273 topics
- Hepatocellular Carcinoma851 topic
- Liver Cancer851 topic
- Neoadjuvant Therapy612 topics
- Chemotherapy572 topics
- Cholangiocarcinoma412 topics
- Prognostic Factors402 topics
- Surgical Management402 topics
- Pancreatic Cancer381 topic
- Surgical Complications381 topic
- Ischemia-Reperfusion Injury311 topic
- Liver Transplantation311 topic
- Biliary Tract Cancer251 topic
- Intrahepatic Cholangiocarcinoma251 topic
- Preoperative Chemoradiotherapy231 topic
- Rectal Cancer231 topic
- Endoscopic Resection191 topic
- Gastric Cancer191 topic
- Cholecystitis161 topic
- ERCP161 topic
- Imatinib Mesylate151 topic
- Sunitinib151 topic
Where does Hironori Kaneko work?
Hironori Kaneko's main affiliation in the publication record is Toho University, Japan.
How many publications and citations does Hironori Kaneko have?
OpenAlex counts 285 works and 8,884 citations for Hironori Kaneko, an h-index of 43, ranking #1,738,189 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hironori Kaneko. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.